Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | GH | BMRN | ||
| Company | Exelixis Inc | Guardant Health Inc | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 90.45 | 54.53 | ||
| High | 45.25 | 92.99 | 55.57 | ||
| Low | 44.44 | 90.00 | 54.31 | ||
| Latest | 44.62 | 90.61 | 55.10 | ||
| Change | -0.27 | +0.25 | +0.46 | ||
| % Change | -0.60% | +0.28% | +0.84% | ||
| Volume | 228,689 | 312,227 | 276,997 | ||
| 20-Day Average Volume | 2,059,150 | 2,100,623 | 1,547,784 | ||
| Previous Close | 44.89 | 90.36 | 54.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.67 | 87.71 | 55.40 | ||
| 20-Day Raw Stochastic | 73.40% | 70.59% | 38.71% | ||
| 20-Day Relative Strength | 55.61 | 51.15 | 45.20 | ||
| Weighted Alpha | +15.25 | +53.42 | -11.32 | ||
| Today's Opinion | 88% Buy | 8% Buy | 40% Sell | ||
| Previous Opinion | 88% Buy | 8% Sell | 40% Sell | ||
| Last Month's Opinion | 24% Sell | 8% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.58% since 04/13/26 | +11.68% since 04/13/26 | +0.33% since 04/13/26 | ||
| Low | 43.97 on 04/16/26 | 83.04 on 04/14/26 | 53.79 on 04/16/26 | ||
| High | 46.10 on 04/15/26 | 92.99 on 04/20/26 | 56.05 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +8.31% since 03/20/26 | +7.78% since 03/20/26 | +1.72% since 03/20/26 | ||
| Low | 40.84 on 03/24/26 | 74.55 on 04/10/26 | 53.35 on 03/24/26 | ||
| High | 46.10 on 04/15/26 | 99.00 on 04/08/26 | 57.76 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +2.10% since 01/20/26 | -20.07% since 01/20/26 | -2.22% since 01/20/26 | ||
| Low | 39.71 on 03/02/26 | 74.55 on 04/10/26 | 53.35 on 03/24/26 | ||
| High | 46.10 on 04/15/26 | 120.74 on 01/22/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +29.42% since 10/20/25 | +30.78% since 10/20/25 | +3.75% since 10/20/25 | ||
| Low | 34.63 on 10/21/25 | 66.59 on 10/23/25 | 50.76 on 11/07/25 | ||
| High | 47.24 on 12/23/25 | 120.74 on 01/22/26 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,402,419 | 11,852,520 | 10,508,528 | ||
| Shares Outstanding, K | 254,008 | 131,170 | 192,323 | ||
| Annual Sales | 2,320,130,000 | 982,020,000 | 3,221,250,000 | ||
| Annual Net Income | 782,570,000 | -416,280,000 | 348,900,000 | ||
| Last Quarter Sales | 598,660,000 | 281,270,000 | 874,560,000 | ||
| Last Quarter Net Income | 244,530,000 | -128,490,000 | -46,570,000 | ||
| 60-Month Beta | 0.42 | 1.64 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.94 on 02/10/26 | -0.50 on 02/19/26 | 0.46 on 02/23/26 | ||
| Latest Earnings Date | 05/12/26 | 04/29/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.26 | 0.00 | 22.26 | ||